Metabolic Dysfunction-Associated Fatty Liver Disease Is Associated with the Risk of Incident Cardiovascular Disease: A Prospective Cohort Study in Xinjiang

In 2020, a group of international experts proposed a new term ‘metabolic dysfunction-associated fatty liver disease’ (MAFLD) to replace ‘non-alcoholic fatty liver disease’. This study aimed to describe the epidemic characteristics of MAFLD, incidence of cardiovascular disease (CVD), and relationship...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Yanbo, Yang, Jing, Ma, Rulin, Zhang, Xianghui, Guo, Heng, He, Jia, Wang, Xinping, Cao, Boyu, Maimaitijiang, Remina, Li, Yu, Peng, Xinyu, Zhang, Shijie, Guo, Shuxia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9231197/
https://www.ncbi.nlm.nih.gov/pubmed/35745091
http://dx.doi.org/10.3390/nu14122361

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9231197/
https://www.ncbi.nlm.nih.gov/pubmed/35745091
http://dx.doi.org/10.3390/nu14122361

Ejemplares similares